News | CT Angiography (CTA) | June 17, 2016

Multi-Society Group Releases CAD-RADS for Standardized Coronary CT Angiography Reporting

System designed to bring uniformity to reporting of stenosis and plaque on coronary CTA

CAD-RADS, coronary CT angiography, CCTA, reporting, SCCT, ACR, NASCI, ACC

A coronary CTA scan from a Philips CT scanner illustrating a curved multiplaner reconstruction showing a large occlusion of the artery.

June 17, 2016 — Three medical professional societies this week jointly released a new reporting system to standardize reporting of patients undergoing coronary computed tomography angiography (coronary CTA). Termed CAD-RADS  (Coronary Artery Disease Reporting and Data System), this system will bring consistency to reporting of coronary CTA diagnostic information for millions of patients worldwide. 

Unlike many other major disease areas, until now no standardized system has existed to classify and report patient data for CT scans of coronary artery disease. CAD-RADS fulfills that long-sought goal of the radiology, cardiology and industry communities.

The suggested CAD-RADS classification is applied on a per-patient basis and represents the highest-grade coronary artery lesion documented by coronary CTA. It ranges from CAD-RADS 0 (zero) for the complete absence of stenosis and plaque to CAD-RADS 5 for the presence of at least one totally occluded coronary artery, and should always be interpreted in conjunction with the impression found in the report. Specific recommendations are provided for further management of patients with stable or acute chest pain based on the CAD-RADS classification.

Ricardo C. Cury, M.D., Miami Cardiac and Vascular Institute, Radiology Associates of South Florida and SCCT past president, led a 17-member multi-disciplinary Expert Consensus Group representing four professional societies: The Society of Cardiovascular Computed Tomography (SCCT, the lead society for CAD-RADS), The American College of Radiology (ACR, co-author), the North American Society for Cardiovascular Imaging (NASCI, co-author) and the American College of Cardiology (ACC, which endorsed this publication). 

 

Watch a video interview with Cury on what CAD-RADS means for cardiology and radiology.

 

Cury noted that "our societies developed CAD-RADS to improve communication of coronary CTA results to referring physicians in a consistent fashion, including considerations for patient management.  Standardized reporting will benefit education, research, peer review and quality assurance and improved quality of care. The teamwork amongst our multi-society, multi-disciplinary writing group was exemplary." 

Cury urges the practice community and industry to become familiar with the CAD-RADS classification and modifiers system. "Today's article is the starting point for a very important process. Next, to promote incorporation of CAD-RADS into daily practice, SCCT will partner with other societies and industry to develop tools for every coronary CTA facility considering adoption of CAD-RADS." 

SCCT President-Elect Leslee J. Shaw, Ph.D. added that the next step will be "development of highly sophisticated decision support tools and registries. CAD-RADS is an important part of our strategic plan to ensure that all patients undergoing CCTA have the highest quality of cardiovascular care."

ACR Chief Executive Officer William T. Thorwarth Jr., M.D., FACR, commented that "The ACR, through our representatives on this important project, was pleased to be a part of this critical effort to enable the standardized reporting and subsequent ongoing evaluation and optimal performance of this valuable examination."

The document was published online in the Journal of Cardiovascular Computed Tomography, the Journal of the American College of Radiology (JACR) and JACC Cardiovascular Imaging

For more information: www.scct.org

Related Content

A cardiac MRI of athletes who had COVID-19 is seven times more effective in detecting inflammation of the heart than symptom-based testing, according to a study led by researchers at The Ohio State University Wexner Medical Center and College of Medicine with 12 other Big Ten programs.

Cardiac Magnetic Resonance Imaging in Athletes With Clinical and Subclinical Myocarditis A-D, Athlete A with subclinical possible myocarditis was asymptomatic with normal electrocardiogram (ECG), echocardiogram, and high-sensitivity troponin findings. A, T2 mapping showing elevated T2 in basal-mid inferolateral wall in short axis view. B, late gadolinium enhancement (LGE) in the basal inferolateral wall in short axis view. C, Postcontrast steady state-free precession (SSFP) images showing contrast uptake in the basal-mid inferolateral wall in short axis view. D, LGE in the inferolateral wall in 3-chamber view. E-H, Athlete B with subclinical probable myocarditis was asymptomatic with normal ECG, normal echocardiogram, and elevated high-sensitivity troponin findings. E, T2 mapping showing elevated T2 in the anteroseptal wall in short axis view. F, LGE in the anteroseptal wall in 3-chamber view. G, T2 mapping showing elevated T2 in the anteroseptal wall in 3-chamber view. F, Postcontrast SSFP image showing pericardial effusion in short axis view. I-K, Athlete C with clinical myocarditis and chest pain, dyspnea, abnormal ECG, normal echocardiogram, and normal troponin findings. I, T2 mapping showing elevated T2 in the lateral wall short axis view. J, Postcontrast SSFP images showing contrast uptake in midlateral wall in short axis view. K, LGE in the epicardial midlateral wall in short axis view. L-N, Athlete D with clinical myocarditis, chest pain, abnormal ECG, echocardiogram, and troponin findings. L, T1 mapping showing elevated native T1 in midlateral wall in short axis view. M, T2 mapping showing elevated T2 in the midlateral wall in short axis view. N, LGE in the epicardial midlateral wall in short axis view. IR indicates inferior right view; IRP, inferior, right, posterior view; PLI, posterior, left, inferior view; SL, superior left view; SLA, superior, left, anterior view. Image courtesy of JAMA Cardiol. Published online May 27, 2021. doi:10.1001/jamacardio.2021.2065

News | Cardiac Imaging | June 15, 2021
June 15, 2021 — A...
Rensselaer algorithm can identify risk of cardiovascular disease using lung cancer scan #CT
News | Computed Tomography (CT) | June 14, 2021
June 14, 2021 — Heart disease and cancer are the ...
Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

Prediction performance of DL compared to quantitative measures and Kaplan-Meier curves for quartiles of DL. Image created by Singh et al., Cedars-Sinai Medical Center, Los Angeles, CA.

News | SPECT Imaging | June 14, 2021
June 14, 2021 — An advanced artificial i...
Accuray Incorporated announced the company has received CE Mark certification for its ClearRT helical fan-beam kVCT imaging capability.
News | Radiation Therapy | June 11, 2021
June 11, 2021 — Accuray Incorporated announced the company has received CE Mark certification for its...
News | PET-CT | June 10, 2021
June 10, 2021 — Bringing the power of...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

An example of how spectral CT can help aid diagnosis in a pancreatic CT which may have a small lesion, but it is difficult to see. The dual-energy imaging clearly shows a lesion. This is example is from the Philips Spectral CT 7500 system.

Feature | Computed Tomography (CT) | May 27, 2021 | By Dave Fornell, Editor
May 27, 2021 — Philips Healthcare released a workhorse...
(A) 70-year-old woman with pulmonary adenocarcinoma who underwent sublobar resection without evidence for pLVI. 15-mm solid nodule with irregular margins present in right lower lobe (arrow). No tumor recurrence on 37-month follow-up. (B) 75-year-old man with pulmonary adenocarcinoma who underwent wedge resection that exhibited pLVI. 19-mm solid nodule with irregular margins and peritumoral interstitial thickening (arrowheads) present in right upper lobe. Ipsilateral mediastinal and hilar lymph node metastas

(A) 70-year-old woman with pulmonary adenocarcinoma who underwent sublobar resection without evidence for pLVI. 15-mm solid nodule with irregular margins present in right lower lobe (arrow). No tumor recurrence on 37-month follow-up. (B) 75-year-old man with pulmonary adenocarcinoma who underwent wedge resection that exhibited pLVI. 19-mm solid nodule with irregular margins and peritumoral interstitial thickening (arrowheads) present in right upper lobe. Ipsilateral mediastinal and hilar lymph node metastasis occurred after 5-month follow-up (not shown). Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Computed Tomography (CT) | May 18, 2021
May 18, 2021 — According to an open-access Editor's Choice article in ARRS' ...